Avelumab-cetuximab-radiotherapy versus standards of care in patients with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Randomized phase III GORTEC-REACH trial

J. Bourhis , Y. Tao , X. Sun , C. Sire , L. Martin , X. Liem , Alexandre Coutte (1) , Y. Pointreau , J. Thariat , J. Miroir , F. Rolland , M-C. Kaminsky , C. Borel , A. Maillard , L. Sinigaglia , J. Guigay , E. Saada-Bouzid , C. Even , A. Auperin

1 CHIMERE - CHirurgie, IMagerie et REgénération tissulaire de l’extrémité céphalique - Caractérisation morphologique et fonctionnelle - UR UPJV 7516

Domaines: Sciences du Vivant [q-bio]

J. Bourhis, Y. Tao, X. Sun, C. Sire, L. Martin, et al.. Avelumab-cetuximab-radiotherapy versus standards of care in patients with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Randomized phase III GORTEC-REACH trial. Annals of Oncology, 2021, 32 (5), pp.S1310. ⟨10.1016/j.annonc.2021.08.2112⟩. ⟨hal-03600467⟩